Health Care Insider Buying
50 health care companies had open-market insider purchases in the last 30 days, ranked below by dollar value. The buyers include officers, directors and 10% owners, and a 10% owner can be a fund. All health care companies ยท How to read insider buying
Purchase value (30d)
50| # | Ticker / Company | Purchase value (30d) |
|---|---|---|
| 1 |  $ADRX ADARx Pharmaceuticals, Inc. | $87.75M |
| 2 |  $KOD Kodiak Sciences Inc. | $58.63M |
| 3 |  $ETRA Electra Therapeutics, Inc. | $40.00M |
| 4 |  $CV CapsoVision, Inc | $15.00M |
| 5 |  $AVR Anteris Technologies Global Corp. | $11.69M |
| 6 |  $PRTA PROTHENA CORP PUBLIC LTD CO | $5.82M |
| 7 |  $CARL CARLSMED, INC. | $3.00M |
| 8 |  $OFIX Orthofix Medical Inc. | $2.73M |
| 9 |  $INBX Inhibrx Biosciences, Inc. | $2.00M |
| 10 |  $COO COOPER COMPANIES, INC. | $1.88M |
| 11 |  $XENE Xenon Pharmaceuticals Inc. | $1.68M |
| 12 |  $ACOG Alpha Cognition Inc. | $1.50M |
| 13 |  $CYBN CYBIN INC. | $1.39M |
| 14 |  $TRXB TRex Bio, Inc. | $1.30M |
| 15 |  $ONMD OneMedNet Corp | $1000K |
| 16 |  $OM Outset Medical, Inc. | $870K |
| 17 |  $IRIX IRIDEX CORP | $603K |
| 18 |  $HRGN Harvard Apparatus Regenerative Technology, Inc. | $394K |
| 19 |  $RTSN Retension Pharmaceuticals, Inc. | $370K |
| 20 |  $SAVA CASSAVA SCIENCES INC | $356K |
| 21 |  $AGMB AgomAb Therapeutics NV | $311K |
| 22 |  $DMRA Damora Therapeutics, Inc. | $253K |
| 23 |  $NAMS NewAmsterdam Pharma Co N.V. | $226K |
| 24 |  $GRCE Grace Therapeutics, Inc. | $217K |
| 25 |  $NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | $216K |
| 26 |  $INM InMed Pharmaceuticals Inc. | $190K |
| 27 |  $ANIX Anixa Biosciences Inc | $181K |
| 28 |  $TELA TELA Bio, Inc. | $167K |
| 29 |  $TENX TENAX THERAPEUTICS, INC. | $133K |
| 30 |  $RDGL VIVOS INC | $101K |
| 31 |  $MAIA MAIA Biotechnology, Inc. | $100K |
| 32 |  $ANNX Annexon, Inc. | $100K |
| 33 |  $ECOR electroCore, Inc. | $98K |
| 34 |  $LPCN Lipocine Inc. | $82K |
| 35 |  $STSS Sharps Technology Inc. | $78K |
| 36 |  $BFRG BullFrog AI Holdings, Inc. | $71K |
| 37 |  $ADAG Adagene Inc. | $70K |
| 38 |  $XAIR Beyond Air, Inc. | $57K |
| 39 |  $NNOX Nano-X Imaging Ltd. | $52K |
| 40 |  $QTEX QTREX Quantum Ltd. | $51K |
| 41 |  $CTSO Cytosorbents Corp | $50K |
| 42 |  $YDES YD Bio Ltd | $49K |
| 43 |  $PETV PetVivo Holdings, Inc. | $40K |
| 44 |  $DYN Dyne Therapeutics, Inc. | $40K |
| 45 |  $GUTS FRACTYL HEALTH, INC. | $40K |
| 46 |  $PHIO Phio Pharmaceuticals Corp. | $31K |
| 47 |  $DTIL PRECISION BIOSCIENCES INC | $30K |
| 48 |  $PALI PALISADE BIO, INC. | $29K |
| 49 |  $CMPX Compass Therapeutics, Inc. | $21K |
| 50 |  $MOBI Mobia Medical, Inc. | $21K |
Why sector matters for insider buying
Insider buying is easier to read next to its own sector. Company officers know their industry's cycle better than the market's. When insiders at several health care companies buy in the same month, the buying points at the industry, which the same number of purchases spread across unrelated industries would not.
Only purchases (SEC Form 4 transaction code P) count. Grants, option exercises and shares withheld for tax are left out: they are pay, not a decision to buy, and counting them would rank sectors by payroll.